MedPath

Center for Research in Security Prices, LLC

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Psychotherapy for Intermittent Explosive Disorder

Not Applicable
Completed
Conditions
Anger
Intermittent Explosive Disorder
Interventions
Behavioral: Cognitive Behavioral Therapy
Behavioral: Supportive Psychotherapy
First Posted Date
2008-04-28
Last Posted Date
2024-08-19
Lead Sponsor
University of Chicago
Target Recruit Count
44
Registration Number
NCT00667212
Locations
🇺🇸

University of Chicago, Chicago, Illinois, United States

Maintaining Intrauterine Devices (IUDs) in Teens (MINT): A Randomization Trial

Phase 4
Completed
Conditions
Contraception
Interventions
Device: Levonorgestrel-releasing intrauterine device (LNG-IUS)
Device: Copper T380A intrauterine device (CuT380A)
First Posted Date
2008-04-04
Last Posted Date
2023-02-23
Lead Sponsor
University of Chicago
Target Recruit Count
23
Registration Number
NCT00653159
Locations
🇺🇸

University of Illinois at Chicago, Chicago, Illinois, United States

🇺🇸

University of Chicago, Chicago, Illinois, United States

Acceptability of the NuvaRing Among Students

Phase 4
Completed
Conditions
Birth Control Compliance
Interventions
Device: NuvaRing
Drug: Ortho Tri-cyclen Lo
First Posted Date
2008-03-13
Last Posted Date
2021-02-03
Lead Sponsor
University of Chicago
Target Recruit Count
273
Registration Number
NCT00635570
Locations
🇺🇸

University of Chicago, Chicago, Illinois, United States

🇺🇸

University of Illinois, Chicago, Illinois, United States

🇺🇸

University of Chicago, Section of Family Planning, Chicago, Illinois, United States

Postplacental Insertion of Levonorgestrel-releasing Intrauterine System (LNG-IUS) After Cesarean vs. Interval Insertion

Not Applicable
Terminated
Conditions
Healthy
Interventions
Device: Levonorgestrel-releasing intrauterine system (LNG-IUS)
First Posted Date
2008-03-13
Last Posted Date
2023-03-22
Lead Sponsor
University of Chicago
Target Recruit Count
42
Registration Number
NCT00635362
Locations
🇺🇸

University of Chicago, Chicago, Illinois, United States

Intranasal CO2 for Allergic Rhinitis

Not Applicable
Completed
Conditions
Allergic Rhinitis
Interventions
Other: Placebo
Device: Carbon dioxide, USP
First Posted Date
2008-02-20
Last Posted Date
2014-01-27
Lead Sponsor
University of Chicago
Target Recruit Count
13
Registration Number
NCT00618410
Locations
🇺🇸

University of Chicago, Chicago, Illinois, United States

The Effects of Sorafenib on Molecular Barrett's Esophagus Cancer

Not Applicable
Terminated
Conditions
Esophageal Cancer
Interventions
First Posted Date
2008-02-20
Last Posted Date
2014-03-12
Lead Sponsor
University of Chicago
Target Recruit Count
3
Registration Number
NCT00619242
Locations
🇺🇸

University of Chicago, Chicago, Illinois, United States

Can a Nasal Decongestant Test Predict Treatment Outcomes in Seasonal Allergic Rhinitis?

Not Applicable
Completed
Conditions
Seasonal Allergic Rhinitis
Interventions
First Posted Date
2008-02-20
Last Posted Date
2014-02-14
Lead Sponsor
University of Chicago
Target Recruit Count
40
Registration Number
NCT00618332
Locations
🇺🇸

University of Chicago, Chicago, Illinois, United States

MRI Study of BAY 43-9006 in Metastatic Renal Cell Carcinoma

Phase 3
Completed
Conditions
Metastatic Renal Cell Carcinoma
Interventions
Drug: placebo
First Posted Date
2008-02-05
Last Posted Date
2023-11-29
Lead Sponsor
University of Chicago
Target Recruit Count
57
Registration Number
NCT00606866
Locations
🇺🇸

The University of Chicago, Chicago, Illinois, United States

Intravenous Immunoglobulin (IVIG) for Treatment of Unexplained Secondary Recurrent Miscarriage

Not Applicable
Completed
Conditions
Miscarriage, Recurrent
Abortion, Habitual
Interventions
Biological: Gamimune N or Gamunex 10%
Other: normal saline
First Posted Date
2008-02-05
Last Posted Date
2012-10-08
Lead Sponsor
University of Chicago
Target Recruit Count
82
Registration Number
NCT00606905
Locations
🇺🇸

The University of Chicago, Chicago, Illinois, United States

Pilot Study of the Treatment of Vascular Endothelial Growth Factor(VEGF)Signaling Pathway Inhibitor-Induced Hypertension

Not Applicable
Terminated
Conditions
Treatment Induced Hypertension
Interventions
First Posted Date
2008-02-05
Last Posted Date
2014-06-10
Lead Sponsor
University of Chicago
Target Recruit Count
2
Registration Number
NCT00607477
Locations
🇺🇸

University of Chicago, Chicago, Illinois, United States

© Copyright 2025. All Rights Reserved by MedPath